drugset / Trial / NCT01917773

Effect of Octreotide on the Colonic Motility in Pediatric Patients

NCT01917773 ↗

Phase 4 Completed 13 enrolled Indiana University
NaSingle-groupOpen-labelSupportive care

Summary

The research study is designed to test how a medication called octreotide affects the motility (contraction or squeezing) of the colon (large intestine). Investigators are investigating whether octreotide can increase contraction and movement in the colon.

Timeline

Start
2013-08
Primary completion
2014-06
Completion
2014-06

Outcome

Missed primary endpoint

registry analysis (non-inferiority or equivalence test); 15 Minutes; p = 0.087; Wilcoxon signed rank test NCT01917773 ↗

registry analysis (superiority or other test); 30 Minutes; p = 0.552; Wilcoxon signed rank test NCT01917773 ↗

registry analysis (superiority or other test); 45 Minutes; p = 0.807; Wilcoxon signed rank test NCT01917773 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Octreotide Peptide — —
Background Bisacodyl Small molecule — —